Metraipolis › archive › dc_a4d2f4e10d24

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 — Europe PMC PMID:33750978

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33750978
DOI
10.1371/journal.pbio.3001128
License (as archived)
CC0-1.0
Archived
2026-11-05T12:46:21.886Z
SHA-256 of the archived text
6e624add9c1d63a4b2e48f1ae62253d9c1fbf0b95b34d709e718fa08ec8b2ea9
Stable URL of this page
https://metraipolis.com/documento/dc_a4d2f4e10d24

How to cite

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 — Europe PMC PMID:33750978 — Europe PMC (en), https://europepmc.org/article/MED/33750978 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_a4d2f4e10d24 (Metraipolis archive dc_a4d2f4e10d24, sha256 6e624add9c1d63a4b2e48f1ae62253d9c1fbf0b95b34d709e718fa08ec8b2ea9)
BibTeX
@misc{dca4d2f4e10d24,
  title = {A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 — Europe PMC PMID:33750978},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33750978},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_a4d2f4e10d24; sha256 6e624add9c1d63a4b2e48f1ae62253d9c1fbf0b95b34d709e718fa08ec8b2ea9},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33750978. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The scientific community is focused on developing antiviral therapies to mitigate the impacts of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated by improved understanding of viral dynamics within infected hosts. Here, using a mathematical model in combination with published viral load data, we compare within-host viral dynamics of SARS-CoV-2 with analogous dynamics of MERS-CoV and SARS-CoV. Our quantitative analyses using a mathematical model revealed that the within-host reproduction number at symptom onset of SARS-CoV-2 was statistically significantly larger than that of MERS-CoV and similar to that of SARS-CoV. In addition, the time from symptom onset to the viral load peak for SARS-CoV-2 infection was shorter than those of MERS-CoV and SARS-CoV. These findings suggest the difficulty of controlling SARS-CoV-2 infection by antivirals. We further used the viral dynamics model to predict the efficacy of potential antiviral drugs that have different modes of action. The efficacy was measured by the reduction in the viral load area under the curve (AUC). Our results indicate that therapies that block de novo infection or virus production are likely to be effective if and only if initiated before the viral load peak (which appears 2-3 days after symptom onset), but therapies that promote cytotoxicity of infected cells are likely to have effects with less sensitivity to the timing of treatment initiation. Furthermore, combining a therapy that promotes cytotoxicity and one that blocks de novo infection or virus production synergistically reduces the AUC with early treatment. Our unique modeling approach provides insights into the pathogenesis of SARS-CoV-2 and may be useful for development of antiviral therapies.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS biology, 2021 (prima pubblicazione 2021-03-22).
Identificativi: PMID 33750978 · PMCID PMC7984623 · DOI 10.1371/journal.pbio.3001128.
Pagina: https://europepmc.org/article/MED/33750978 — https://doi.org/10.1371/journal.pbio.3001128. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T12:39:03.961Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.